Evidence map›Paper›PMID 41104587›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2026

Analyzing the 'Bradykinesia Complex' in Parkinson's Disease.

Giulia Paparella, Martina De Riggi, Antonio Cannavacciuolo, Daniele Birreci, Davide Costa, Luca Angelini, Danilo Alunni Fegatelli, Alfonso Fasano, Alberto J Espay, Matteo Bologna

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Orofacial Drinking Tremor: A Case Series and Literature Review.Movement disorders clinical practice · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Shopping bag tremor: insights from kinematic analysis.Clinical neurophysiology practice · 2026
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giulia PaparellaIRCCS Neuromed, Pozzilli, Italy.ORCID https://orcid.org/0000-0002-7760-9442
Martina De RiggiDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0009-0002-2518-4259
Antonio CannavacciuoloIRCCS Neuromed, Pozzilli, Italy.ORCID https://orcid.org/0000-0002-1653-706X
Daniele BirreciDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0009-0004-8000-1886
Davide CostaDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0009-0008-6299-4449
Luca AngeliniIRCCS Neuromed, Pozzilli, Italy.ORCID https://orcid.org/0000-0002-6601-7476
Danilo Alunni FegatelliDepartment of Life Sciences, Health and Health Professions, Link Campus University, Rome, Italy.ORCID https://orcid.org/0009-0003-0386-5237
Alfonso FasanoDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.ORCID https://orcid.org/0000-0001-5346-0180
Alberto J EspayJames J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.ORCID https://orcid.org/0000-0002-3389-136X
Matteo BolognaIRCCS Neuromed, Pozzilli, Italy.ORCID https://orcid.org/0000-0003-0165-0833

Funding

Ministero della Salute Current Research 2025
6 · The paper itself

Abstract

backgroundBradykinesia is the hallmark sign of parkinsonism. We recently proposed redefining bradykinesia as a complex of motor abnormalities, each reflecting separate pathophysiological elements.

objectiveTo analyze the 'bradykinesia complex' in Parkinson's disease (PD) and healthy elderly individuals.

methodsWe conducted a finger-tapping kinematic analysis in 350 individuals (192 PD patients OFF medication and 158 healthy controls). A subsample of 129 patients was also tested ON medication. Group comparisons were followed by unsupervised clustering. Receiver operating characteristic (ROC) analyses defined optimal kinematic cut-offs to detect individual motor abnormalities. We then quantified the prevalence and combinations of these features per subject. Using Bayes' theorem, we estimated the probability of PD based on the observed combination of bradykinesia features. Regression analyses served to identify predictors of kinematic alterations.

resultsPatients exhibited reduced velocity and amplitude as well as altered rhythm and sequence effect compared with controls (all P-values < 0.001). Cluster analysis revealed substantial group overlap. ROC analyses showed that bradykinesia (movement slowness) was the most common and accurate feature for distinguishing PD, with its diagnostic power improving when combined with other motor abnormalities (hypokinesia, dysrhythmia, sequence effect). The likelihood of correctly identifying PD increased with the number of observed abnormalities, reaching up to 95% when all features were present. Levodopa improved motor performance, but the motor abnormality patterns remained unchanged.

conclusionsThe detailed bradykinesia features assessment was crucial for differentiating PD individuals from controls. Diagnostic accuracy requires considering multiple motor abnormalities together, irrespective of the specific combination. Advancing our understanding of the 'bradykinesia complex' has clinical and pathophysiological implications. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

HypokinesiaParkinson DiseaseAgedBiomechanical PhenomenaFemaleHumansMaleMiddle AgedROC Curveagingbradykinesiafinger‐tappingkinematic analysisParkinson's disease

Identifiers

PMID41104587
PMCPMC12882039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.